Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
LCC Medical Research Institute, LLC
mi
from
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
LCC Medical Research Institute, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Oceane7 Clinical Research, Llc
mi
from
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Oceane7 Clinical Research, Llc
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
RM Medical Research, Inc.
mi
from
Miami, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
RM Medical Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
IMIC
mi
from
Palmetto Bay, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
IMIC
mi
from
Palmetto Bay, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Clinical Research Trials of Florida, Inc.
mi
from
Tampa, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Clinical Research Trials of Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Meridien Research
mi
from
Tampa, FL
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Heartland Research Associates, LLC
mi
from
Augusta, KA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Heartland Research Associates, LLC
mi
from
Augusta, KA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Dermatology Specialists Research
mi
from
Louisville, KY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Dermatology Specialists Research
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
DermResearch, PLLC
mi
from
Louisville, KY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Core Healthcare Group
mi
from
Cerritos, LA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Core Healthcare Group
mi
from
Cerritos, LA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
DelRicht Research
mi
from
New Orleans, LA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
DelRicht Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
MediSearch Clinical Trials
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
eStudySite
mi
from
Las Vegas, NV
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
eStudySite
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
ActivMed Practices & Research, Inc.
mi
from
Portsmouth, NH
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
ActivMed Practices & Research, Inc.
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
New York Clinical Trials
mi
from
Manhattan, NY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
New York Clinical Trials
mi
from
Manhattan, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Dermatology Consulting Services
mi
from
High Point, NC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Palmetto Clinical Trial Services, LLC @ Greenville Dermatology
mi
from
Greenville, SC
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Palmetto Clinical Trial Services, LLC @ Greenville Dermatology
mi
from
Greenville, SC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Discover Research
mi
from
Bryan, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Discover Research
mi
from
Bryan, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
West Houston Clinical Research Services
mi
from
Houston, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
West Houston Clinical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated:  10/3/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Status: Enrolling
Updated: 10/3/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated:  10/4/2017
Stanford University
mi
from
Stanford, CA
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 10/4/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study
Status: Enrolling
Updated:  10/4/2017
Poudre Valley Health System
mi
from
Fort Collins, CO
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Topical Use of a Silibin-based Cream, Difinsa53™, to Prevent Radiation Dermatitis in Patients With Breast Cancer: A Prospective Study
Status: Enrolling
Updated: 10/4/2017
Poudre Valley Health System
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Heartland NCORP
mi
from
Decatur, IL
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Heartland NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
University of Rochester
mi
from
Rochester, NY
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Columbus NCORP
mi
from
Columbus, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Columbus NCORP
mi
from
Columbus, OH
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Dayton Oncology Research Program
mi
from
Dayton, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Dayton Oncology Research Program
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Radiant Research, Inc.
mi
from
Tucson, AZ
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Radiant Research, Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Dermatology Research of Arkansas
mi
from
Little Rock, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Dermatology Research of Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Hull Dermatology, P.A.
mi
from
Rogers, AR
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Hull Dermatology, P.A.
mi
from
Rogers, AR
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Shahram Jacobs, M.D., Inc.
mi
from
Encino, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Shahram Jacobs, M.D., Inc.
mi
from
Encino, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of California, San Diego Dermatology Clinical Trials Unit
mi
from
La Jolla, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of California, San Diego Dermatology Clinical Trials Unit
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Dermatology Research Associates
mi
from
Los Angeles, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Laser and Dermatology Center
mi
from
Marina del Rey, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Laser and Dermatology Center
mi
from
Marina del Rey, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Integrated Research Group
mi
from
Riverside, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Integrated Research Group
mi
from
Riverside, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
University of California-Davis
mi
from
Sacramento, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Therapeutics Clinical Research
mi
from
San Diego, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
East Bay Psoriasis Treatment Center
mi
from
San Ramon, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
East Bay Psoriasis Treatment Center
mi
from
San Ramon, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Stanford University Dept of Dermatology
mi
from
Stanford, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Stanford University Dept of Dermatology
mi
from
Stanford, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Solano Clinical Research, Dow Pharmaceutical Sciences
mi
from
Vallejo, CA
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Solano Clinical Research, Dow Pharmaceutical Sciences
mi
from
Vallejo, CA
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Longmont Clinic, PC
mi
from
Longmont, CO
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Longmont Clinic, PC
mi
from
Longmont, CO
Click here to add this to my saved trials
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated:  10/9/2017
Western State Clinical Research Inc.
mi
from
Wheat Ridge, CO
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status: Enrolling
Updated: 10/9/2017
Western State Clinical Research Inc.
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials